• 

  Renal myopericytoma: A case report and literature review

  Riley, T.; Shenjere, Patrick; Jain, A.; Sunder, S.; North Manchester General Hospital, Pennine Acute NHS Hospitals Trust, Delaunay's Road, Manchester, M8 5RB (2021)

  Renal myopericytoma is an extremely rare entity with just 11 cases reported in the literature. We report the case of a 57 year old Caucasian man who was found to have a renal myopericytoma following nephrectomy for suspected renal cell carcinoma. Renal myopericytoma has a distinct morphological overlap with other pericytic tumours and significant histological variation has been noted between cases reported to date. Further characterising this novel tumour is vital to identify subtypes within this spectrum, understand its behaviour and to identify imaging trends which may lead to pre-operative diagnosis in order to potentially avoid radical treatment.
• 

  Correction to: the impact of COVID-19 on interventional radiology services in the UK

  Zhong, J.; Datta, Anubhav; Gordon, T.; Adams, S.; Guo, T.; Abdelaziz, M.; Barbour, F.; Palkhi, E.; Adusumilli, P.; Oomerjee, M.; et al. (2021)

  None
• 

  Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era

  Rodriguez-Freixinos, V.; Capdevila, J.; Pavel, M.; Thawer, A.; Baudin, E.; O'Toole, D.; Herrmann, K.; Welin, S.; Grozinsky-Glasberg, S.; de Herder, W. W.; et al. (2020)

  Neuroendocrine neoplasms (NENs) are a heterogeneous family of uncommon tumours with challenging diagnosis, clinical management and unique needs that almost always requires a multidisciplinary approach. In the absence of guidance from the scientific literature, along with the rapidly changing data available on the effect of COVID-19, we report how 12 high-volume NEN centres of expertise in 10 countries at different stages of the evolving COVID-19 global pandemic along with members of international neuroendocrine cancer patient societies have suggested to preserve high standards of care for patients with NENs. We review the multidisciplinary management of neuroendocrine neoplasms during the COVID-19 pandemic, and we suggest potential strategies to reduce risk and aid multidisciplinary treatment decision-making. By sharing our joint experiences, we aim to generate recommendations for proceeding to other institutions facing the same challenges.
• 

  Tribute to David Thwaites

  Georg, D.; van der Heide, U. A.; Aznar, Marianne Camille; Baumann, M.; Division Medical Radiation Physics, Department of Radiation Oncology, Medical University of Vienna/AKH Wien, Austria. (2020)

  None
• 

  Education to improve cancer care for LGBTQ+ patients in the UK

  Berner, A. M.; Webster, R.; Hughes, D. J.; Tharmalingam, H.; Saunders, Daniel; Barts Cancer Institute, Queen Mary University of London, London, UK; Gender Identity Clinic, The Tavistock and Portman NHS Foundation Trust, London, UK. (2020)

  None

View more